Long-term effects of increased adoption of artemisinin combination therapies in Burkina Faso

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institutes of Health (R01AI153355) and the Bill & Melinda Gates Foundation grants OPP159934 to the University of Washington and INV-005517 to Pennsylvania State University. Simulations described in this study were performed on the Pennsylvania State University’s Institute for Computational and Data Sciences’ Roar supercomputer.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes